This activity is intended for clinicians actively engaged in managing AMR in transplant patients, including transplant physicians, surgeons, NPs, and PAs with an interest in transplant.
The goal of this activity is to provide education about AMR treatment principles, guidelines, and emerging therapies. Faculty will discuss the genesis of alloantibody production and how it contributes to graft loss, as well as unmet needs in AMR therapies. An experienced patient with AMR provides insights for transplant clinicians to consider when treating their patients with AMR.